7 Paid Clinical Research Studies in Stamford, Connecticut

DARA RVD For High Risk SMM

The purpose of this research study is to learn whether the combination of daratumumab SC ( Darzalex Faspro), lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone works i

📍 Stamford Hospital — Stamford, Connecticut

TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

In this research study, investigators are testing if a dose-increasing strategy for abemaciclib will have less side effects and be better tolerated than the standard dosage of abem

📍 Stamford Hospital — Stamford, Connecticut

💵 * ECOG performance status 0-1 * Men and women with any menopausal status ≥18 years of age * Adequate organ function as d

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

This research study is studying a combination of HER2-directed therapies (trastuzumab and pertuzumab) and hormonal therapy as a treatment after surgery for hormone receptor positiv

📍 Stamford Hospital — Stamford, Connecticut

💵 * Participants will receive HER2-directed treatment for 1 year and hormonal therapy for approximately 5 years.

Evaluating the Safety and Clinical Efficacy of the BAIBYS™ System in Intracytoplasmic Sperm Injection (ICSI)

This study looks at an investigational automated, artificial intelligence (AI)-based sperm selection technology called the BAIBYS™ System. We want to see how it compares to current

📍 New England Fertility Institute — Stamford, Connecticut

Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis

The purpose of this study is to assess the ability of long-duration high-frequency continuous-wave therapeutic ultrasound to alleviate knee Osteoarthritis pain over an 12-week peri

📍 Orthopaedic Foundation — Stamford, Connecticut

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasi

📍 Stamford Hospital — Stamford, Connecticut

💵 * Group A: Sacituzumab Govitecan on days 1 and 8 and Pembrolizumab on day 1 of a 21-day cycle * Group B: Sacituzumab Gov

Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-qua

📍 New England Fertility Institute — Stamford, Connecticut